Eur Rev Med Pharmacol Sci 2021; 25 (5): 2159-2159

DOI: 10.26355/eurrev_202103_25247

FOXK1 promotes malignant progression of breast cancer by activating PI3K/AKT/mTOR signaling pathway

Z.-Q. Li, M. Qu, H.-X. Wan, H. Wang, Q. Deng, Y. Zhang

Department of Oncology, Sanya People’s Hospital, Sanya, China.


We detected some serious inaccuracies and mistakes. Therefore, the article “FOXK1 promotes malignant progression of breast cancer by activating PI3K/AKT/mTOR signaling pathway, by Z.-Q. Li, M. Qu, H.-X. Wan, H. Wang, Q. Deng, Y. Zhang, published in Eur Rev Med Pharmacol Sci 2019; 23 (22): 9978-9987–DOI: 10.26355/eurrev_201911_19564–PMID: 31799667” has been withdrawn.

The Publisher apologizes for any inconvenience this may cause.

FOXK1 promotes malignant progression of breast cancer by activating PI3K/AKT/mTOR signaling pathway

Free PDF Download

To cite this article

Z.-Q. Li, M. Qu, H.-X. Wan, H. Wang, Q. Deng, Y. Zhang
FOXK1 promotes malignant progression of breast cancer by activating PI3K/AKT/mTOR signaling pathway

Eur Rev Med Pharmacol Sci
Year: 2021
Vol. 25 - N. 5
Pages: 2159-2159
DOI: 10.26355/eurrev_202103_25247